Practitioner may elect not to reduce dose for other toxicities unlikely to become serious or life-threatening
Severity: Learn more about your pharmacy benefits with Select Health Advantage
This document includes a list of the drugs (formulary) for our plan, which is current as of January 1, 2023
2024 Formulary/Prescription Drug List (PDF) Deserves a Pharmacy Unlike Any Other
Clinical Pracitice Guidelines in Oncology (NCCN Guidelines)
It is not intended to be medical advice
The FEP Blue Focus formulary has two tiers of drugs
The enclosed formulary is current as of 10/01/2021
A formal determination process has been developed to supplement the long-standing evidence-based process by AHFS for evaluation of off-label cancer uses of drugs and biologics
The latest versions are available below
Use an alternative drug; if not possible, determine the residual DPD activity in mononuclear cells from peripheral blood and adjust the initial dose accordingly, or adjust the initial dose based on efficacy and toxicity
To view formulary information first create a list of plans